Fragment-Based Drug Discovery
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | == | + | == Anti-Apoptotic Protein: Bcl-xl == |
<StructureSection load='1ysi' size='500' side='right' caption='Structure of Bcl-xl/Paclitaxel complex (PDB entry [[1ysi]])' scene=''> | <StructureSection load='1ysi' size='500' side='right' caption='Structure of Bcl-xl/Paclitaxel complex (PDB entry [[1ysi]])' scene=''> | ||
| - | This represents the binding of | + | This represents the binding of an <scene name='Sandbox_reserved_394/Paclitaxel/1'>acyl-sulfonamide</scene> to the anti-apoptotic protein, <scene name='Sandbox_reserved_394/Bcl-xl/1'>Bcl-xl</scene>. The protein includes seven <scene name='Sandbox_reserved_394/Alpha_helices/1'>alpha helices</scene> and no beta sheets. |
Revision as of 00:15, 3 October 2012
Anti-Apoptotic Protein: Bcl-xl
| |||||||||||
References
- ↑ Oltersdorf T., Elmore S.W., Shoemaker A.R. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Vol 435|2 June 2005|doi:10.1038/nature03579
